Incannex Healthcare Limited
IXHL
NASDAQ·Healthcare·Biotechnology·Mkt cap $38.8M
$3.25
▼ -0.15%
P/E
-1.16
Mkt Cap
$38.8M
52-Wk Range
$2.49–$20.31
52-Week Range
$2.49 - $20.31
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 81.4% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary cannabinoid formulations with clinical validation
- Strategic partnerships with leading hospitals and research institutions
- Regulatory expertise in Australian medicinal cannabis market
- Clinical-stage pipeline targeting underserved medical indications
Bear Case
1 risk
- High volatility (beta 2.8). Larger-than-normal price swings expected.
Growth
Stable outlook
Progression of IHL-42X through Phase II sleep apnea trials
Value
Deep value opportunity - significant discount to Large Cap Pharma peers
Momentum
Stable
-4.6% over 3m
Quality
Loss-making
Below average quality
Dividend
None
No dividend
Smart-money signal
Who's buying IXHL right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Sep 2, 2026
Most recent quarter reported revenue of $0 (-100% YoY). Reported EPS of -$0.60.
Reported EPS · last 4Q
Q2 25
-$0.60
Q4 25
-$0.60
Q3 25
-$0.60
Q2 24
-$0.99
Revenue trend · last 8Q
—
—
—
—
—
—
+271%
-100%
Q2 23
Q3 24
Q4 24
Q1 24
Q2 24
Q3 25
Q4 25
Q2 25
$0
$0
$18.0K
$109.0K
$19.4K
$0
$66.6K
$0
Margins · last 8Q
Gross
—
Profit
—
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Alliance Global Partners · Jun 8, 2026
vs Industry
How IXHL stacks vs Biotechnology
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related